Crossmark Global Holdings, Inc. Moderna, Inc. Transaction History

Crossmark Global Holdings, Inc.

$5.61 Billion
Q3 2024

A detailed history of Crossmark Global Holdings, Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Crossmark Global Holdings, Inc. holds 13,917 shares of MRNA stock, worth $567,256. This represents 0.02% of its overall portfolio holdings.

Number of Shares

13,917

Previous 14,032 0.82%

Holding current value

$567,256

Previous $1.67 Million 44.18%

% of portfolio

0.02%

Previous 0.03%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$63.64 - $125.14 $7,318 - $14,391	-115 Reduced 0.82%	13,917 $930,000
Q2 2024 Jul 29, 2024	SELL	$101.21 - $166.61 $26,820 - $44,151	-265 Reduced 1.85%	14,032 $1.67 Million
Q1 2024 May 13, 2024	SELL	$85.37 - $115.44 $19,378 - $26,204	-227 Reduced 1.56%	14,297 $1.52 Million
Q4 2023 Feb 13, 2024	SELL	$69.51 - $104.43 $18,976 - $28,509	-273 Reduced 1.84%	14,524 $1.44 Million
Q3 2023 Nov 08, 2023	SELL	$96.41 - $126.61 $23,909 - $31,399	-248 Reduced 1.65%	14,797 $1.55 Million
Q2 2023 Jul 31, 2023	BUY	$118.5 - $160.53 $22,515 - $30,500	190 Added 1.28%	15,045 $1.79 Million
Q1 2023 May 12, 2023	SELL	$135.66 - $197.02 $85,330 - $123,925	-629 Reduced 4.06%	14,855 $2.28 Million
Q4 2022 Jan 19, 2023	BUY	$118.38 - $210.04 $83,694 - $148,498	707 Added 4.78%	15,484 $2.78 Million
Q3 2022 Nov 01, 2022	BUY	$118.07 - $194.18 $22,905 - $37,670	194 Added 1.33%	14,777 $1.75 Million
Q2 2022 Jul 29, 2022	SELL	$117.13 - $176.59 $86,676 - $130,676	-740 Reduced 4.83%	14,583 $2.08 Million
Q1 2022 May 11, 2022	SELL	$126.46 - $235.05 $161,868 - $300,864	-1,280 Reduced 7.71%	15,323 $2.64 Million
Q4 2021 Jan 10, 2022	BUY	$225.82 - $368.51 $164,848 - $269,012	730 Added 4.6%	16,603 $4.22 Million
Q3 2021 Oct 21, 2021	BUY	$221.9 - $484.47 $3.52 Million - $7.69 Million	15,873 New	15,873 $6.11 Million
Q3 2021 Oct 13, 2021	SELL	$221.9 - $484.47 $455,560 - $994,616	-2,053 Closed	0 $0
Q2 2021 Jul 21, 2021	SELL	$129.91 - $234.98 $2,598 - $4,699	-20 Reduced 0.96%	2,053 $482,000
Q1 2021 Apr 15, 2021	BUY	$109.18 - $185.98 $1,091 - $1,859	10 Added 0.48%	2,073 $271,000
Q4 2020 Jan 14, 2021	BUY	$65.74 - $169.86 $135,621 - $350,421	2,063 New	2,063 $216,000

Others Institutions Holding MRNA

# of Institutions

953

Shares Held

241M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.9B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Crossmark Global Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Crossmark Global Holdings, Inc. with notifications on news.

Account

Crossmark Global Holdings, Inc. Moderna, Inc. Transaction History